Risk Factors and Outcomes for Atherothrombotic Disease in French Patients: The RIVAGE Study
- 15 August 1999
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 95 (4) , 163-176
- https://doi.org/10.1016/s0049-3848(99)00045-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Wine, alcohol, platelets, and the French paradox for coronary heart diseaseThe Lancet, 1992
- The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patientsAtherosclerosis, 1991
- Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation, 1991
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984